rorer group inc armour pharmaceutical said received food and drug administration approval for blood clotting drug for hemophiliacs company said drug monoclate antihemophilic factor will treat hemophilia most common form hereditary blood clotting disorder monoclate pct free unwanted contaminants compared blood products which less pct pure armour said reuter 